Authors: Jurianz, K Ziegler, S Donin, N Reiter, Y Fishelson, Z Kirschfink, M

Citation: K. Jurianz et al., K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement, INT J CANC, 93(6), 2001, pp. 848-854

Authors: Jurianz, K Von Hoegen, P Schirrmacher, V

Citation: K. Jurianz et al., Immunological and molecular characterization of an aggressive murine lymphoma variant: Modulation in vitro and in vivo, INT J ONCOL, 15(1), 1999, pp. 71-79

Authors: Schirrmacher, V Jurianz, K Roth, C Griesbach, A Bonifer, R Zawatzky, R

Citation: V. Schirrmacher et al., Tumor stimulator cell modification by infection with Newcastle Disease Virus: Analysis of effects and mechanism in MLTC-CML cultures, INT J ONCOL, 14(2), 1999, pp. 205-215

Authors: Jurianz, K Maslak, S Garcia-Schuler, H Fishelson, Z Kirschfink, M

Citation: K. Jurianz et al., Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2, IMMUNOPHARM, 42(1-3), 1999, pp. 209-218

Authors: Jurianz, K Ziegler, S Garcia-Schuler, H Kraus, S Bohana-Kashtan, O Fishelson, Z Kirschfink, M

Citation: K. Jurianz et al., Complement resistance of tumor cells: Basal and induced mechanisms, MOL IMMUNOL, 36(13-14), 1999, pp. 929-939